CONTINUE TO SITE >
OR WAIT 15 SECS
- About Us
- Advertise
- Contact Us
- Editorial Info
- Editorial Contacts
- Editorial Advisory Board
- Do Not Sell My Personal Information
- Privacy Policy
- Terms and Conditions
© 2021 MJH Life Sciences™ and Pharmaceutical Technology. All rights reserved.
Understanding and Implementing a Risk-Based Approach to 21 CFR Part 11 Compliance
July 2, 2003
Pharmaceutical Technology, Pharmaceutical Technology-07-02-2003, Volume 27, Issue 7
Pharmaceutical companies must take a holistic look at their systems and supporting processes to implement FDA's risk-based approach into their 21 CFR Part 11 complaince strategies.